Therapeutic Goods (Adverse Events Following Immunisation) (Information) Specification 2021

Dated 12 March 2021

Dr Jane Cook

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Definitions................................................................................................................................ 1

5  Release of therapeutic goods information................................................................................. 2

Schedule 1—Therapeutic goods information                                                             3

1  Name

                   This instrument is the Therapeutic Goods (Adverse Events Following Immunisation) (Information) Specification 2021.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 61(5AB) of the Therapeutic Goods Act 1989.

4  Definitions

Note:          A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:

(a)    health practitioner;

(b)    Secretary;

(c)    State; and

(d)    therapeutic goods.

                   In this instrument:

Act means the Therapeutic Goods Act 1989.

AEFI means an adverse event that occurs in relation to a person in Australia following immunisation with a vaccine.

JIC means a Jurisdictional Immunisation Coordinator for a State.

Note:          State is defined in section 3 of the Act as including the Australian Capital Territory and the Northern Territory.

NCIRS means the National Centre for Immunisation Research and Surveillance (ABN 53 188 579 090).

Regulations means the Therapeutic Goods Regulations 1990.

SAEFVIC means the Surveillance of Adverse Events Following Vaccination In the Community, funded by the Department of Health, Victoria.

Note:          SAEFVIC is comprised of two units at the following sites:

(a)    Murdoch Children’s Research Institute (Clinical); and

(b)    Monash Health & University (Epidemiology and Signal Investigation).

TGA ADR report means an adverse drug reaction report made to the Therapeutic Goods Administration in relation to an adverse event associated with a vaccine.

TGA means Therapeutic Goods Administration.

Therapeutic Goods Administration has the same meaning as in the Regulations.

therapeutic goods information has the meaning given by subsection 61(1) of the Act.

5  Release of therapeutic goods information

For subsection 61(5AA) of the Act, in relation to each item, the kinds of therapeutic goods information specified in column 2 of the table in Schedule 1, may be released to the persons or bodies specified in column 3, for the purposes specified in column 4 of the table.

Note:          Under subsection 61(5AA) of the Act, the Secretary may release to a person or body that is specified under subsection 61(5AB), specified kinds of therapeutic goods information for a specified purpose.

Schedule 1—Therapeutic goods information

Note:       See section 5.